Inventor
DE KRUIF CORNELIS ADRIAAN
NL38 patents
⚠️ This page may combine multiple inventors who share the name “DE KRUIF CORNELIS ADRIAAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERUS NV
16 patentsUS9758805B2Sep 12, 2017
Methods and means for the production of Ig-like molecules
MERUS NV23 citations94
US11279770B2Mar 22, 2022
Antibody that binds ErbB-2 and ErbB-3
MERUS NV7 citations85
US10752929B2Aug 25, 2020
Methods and means for the production of ig-like molecules
MERUS NV5 citations84
US10337045B2Jul 2, 2019
Methods and means for the production of Ig-like molecules
MERUS NV3 citations84
US10329596B2Jun 25, 2019
Methods and means for the production of Ig-like molecules
MERUS NV4 citations84
US12139548B2Nov 12, 2024
Antibody that binds ErbB-2 and ErbB-3
MERUS NV4 citations74
US12123043B2Oct 22, 2024
Methods and means for the production of Ig-like molecules
MERUS NV1 citations73
US11926859B2Mar 12, 2024
Methods and means for the production of Ig-like molecules
MERUS NV2 citations73
US11753470B2Sep 12, 2023
Bispecific anti PD1-anti TIM3 antibodies
MERUS NV2 citations71
US11732043B2Aug 22, 2023
Antibodies that modulate a biological activity expressed by a cell
MERUS NV3 citations71
US11667714B2Jun 6, 2023
Binding molecules that modulate a biological activity expressed by a cell
MERUS NV3 citations71
US11952424B2Apr 9, 2024
Multivalent antibody
MERUS NV1 citations62
US12577306B2Mar 17, 2026
Bispecific anti PD1-anti TIM3 antibodies
MERUS NV0 citations61
US11685786B2Jun 27, 2023
Binding molecules that bind CD137 and PD-L1
MERUS NV1 citations61
US12570747B2Mar 10, 2026
TGF-beta-RII binding proteins
MERUS NV0 citations51
US11773170B2Oct 3, 2023
Antibodies that bind EGFR and cMET
MERUS NV0 citations50
CRUCELL HOLLAND BV
8 patentsUS7960518B2Jun 14, 2011
Human binding molecules having killing activity against enterococci and uses thereof
CRUCELL HOLLAND BV45 citations97
US7740852B2Jun 22, 2010
Binding molecules capable of neutralizing rabies virus and uses thereof
CRUCELL HOLLAND BV46 citations94
US8052974B2Nov 8, 2011
Host cell specific binding molecules capable of neutralizing viruses and uses thereof
CRUCELL HOLLAND BV34 citations92
US7901919B2Mar 8, 2011
Chimaeric phages
CRUCELL HOLLAND BV26 citations92
US7858086B2Dec 28, 2010
Binding molecules for treatment and detection of cancer
CRUCELL HOLLAND BV34 citations92
US7329530B2Feb 12, 2008
Chimaeric phages
CRUCELL HOLLAND BV33 citations92
US7244430B2Jul 17, 2007
Binding molecules capable of neutralizing West Nile virus and uses thereof
CRUCELL HOLLAND BV28 citations92
US7537764B2May 26, 2009
Binding molecules capable of neutralizing west nile virus and uses thereof
CRUCELL HOLLAND BV11 citations84
THROSBY MARK
5 patentsUS8241631B2Aug 14, 2012
Human binding molecules having killing activity against enterococci and uses thereof
THROSBY MARK31 citations92
US8211431B2Jul 3, 2012
Human binding molecules having killing activity against staphylococci and uses thereof
THROSBY MARK37 citations90
US8642513B2Feb 4, 2014
Method for preparing immunoglobulin libraries
THROSBY MARK8 citations83
US8628776B2Jan 14, 2014
Human binding molecules against enterococci and Staphylococcus
THROSBY MARK6 citations83
US8460666B2Jun 11, 2013
Human binding molecules having killing activity against staphylococci and uses thereof
THROSBY MARK7 citations81
VAN DEN BRINK EDWARD NORBERT
3 patentsUS8691223B2Apr 8, 2014
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
VAN DEN BRINK EDWARD NORBERT63 citations97
US8192927B2Jun 5, 2012
Human bind molecules capable of neutralizing influenza virus h5n1 and uses thereof
VAN DEN BRINK EDWARD NORBERT53 citations97
US9011848B2Apr 21, 2015
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
VAN DEN BRINK EDWARD NORBERT0 citations51